A detailed history of American Trust transactions in Exact Sciences Corp stock. As of the latest transaction made, American Trust holds 3,359 shares of EXAS stock, worth $195,191. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,359
Holding current value
$195,191
% of portfolio
0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 29, 2024

BUY
$42.43 - $70.83 $142,522 - $237,917
3,359 New
3,359 $228,000
Q1 2024

Jun 11, 2024

BUY
$56.27 - $73.77 $169,879 - $222,711
3,019 New
3,019 $208,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $42,747 - $64,824
-682 Reduced 16.94%
3,345 $314,000
Q1 2023

May 22, 2023

SELL
$47.19 - $70.77 $5,898 - $8,846
-125 Reduced 3.01%
4,027 $273,000
Q4 2022

Feb 16, 2023

SELL
$30.35 - $53.15 $445,568 - $780,295
-14,681 Reduced 77.95%
4,152 $205,000
Q3 2022

Dec 02, 2022

BUY
$31.97 - $49.37 $33,728 - $52,085
1,055 Added 5.93%
18,833 $612,000
Q2 2022

Oct 03, 2022

SELL
$35.61 - $76.23 $75,884 - $162,446
-2,131 Reduced 10.7%
17,778 $700,000
Q1 2022

Jun 08, 2022

BUY
$57.56 - $82.54 $952,905 - $1.37 Million
16,555 Added 493.59%
19,909 $1.39 Million
Q4 2021

Mar 17, 2022

BUY
$72.5 - $100.68 $243,165 - $337,680
3,354 New
3,354 $261,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track American Trust Portfolio

Follow American Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.